Company registration number SC525705 (Scotland)
MEDICO LEGAL SCOTLAND LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
PAGES FOR FILING WITH REGISTRAR
MEDICO LEGAL SCOTLAND LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MEDICO LEGAL SCOTLAND LIMITED
BALANCE SHEET
AS AT
28 FEBRUARY 2026
28 February 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Intangible assets
4
5,646
-
0
Tangible assets
5
49,932
55,205
55,578
55,205
Current assets
Debtors
6
115,420
91,580
Cash at bank and in hand
60,532
83,790
175,952
175,370
Creditors: amounts falling due within one year
7
(94,960)
(81,350)
Net current assets
80,992
94,020
Total assets less current liabilities
136,570
149,225
Creditors: amounts falling due after more than one year
8
(10,323)
(25,691)
Provisions for liabilities
(13,894)
(13,801)
Net assets
112,353
109,733
Capital and reserves
Called up share capital
9
2
2
Profit and loss reserves
112,351
109,731
Total equity
112,353
109,733
MEDICO LEGAL SCOTLAND LIMITED
BALANCE SHEET (CONTINUED)
AS AT
28 FEBRUARY 2026
28 February 2026
- 2 -

For the financial year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 1 July 2026 and are signed on its behalf by:
S Robertson
Director
Company registration number SC525705 (Scotland)
MEDICO LEGAL SCOTLAND LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 3 -
1
Accounting policies
Company information

Medico Legal Scotland Limited is a private company limited by shares incorporated in Scotland. The registered office is 16 Robertson Street, Glasgow, G2 8DS.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover represents amounts receivable from medical legal reporting and services during the year, exclusive of VAT.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website costs
10% straight line
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
15% Reducing Balance
Fixtures and fittings
15% Reducing Balance
Computers
33% Reducing Balance
Motor vehicles
20% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

MEDICO LEGAL SCOTLAND LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
1
Accounting policies
(Continued)
- 4 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

MEDICO LEGAL SCOTLAND LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
1
Accounting policies
(Continued)
- 5 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations. The contributions are recognised as an expense in the Statement of comprehensive income when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the company in independently administered funds.

1.12
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
2
MEDICO LEGAL SCOTLAND LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 6 -
4
Intangible fixed assets
Other
£
Cost
At 1 March 2025
-
0
Additions
6,000
At 28 February 2026
6,000
Amortisation and impairment
At 1 March 2025
-
0
Amortisation charged for the year
354
At 28 February 2026
354
Carrying amount
At 28 February 2026
5,646
At 28 February 2025
-
0
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 March 2025
91,216
Additions
5,944
At 28 February 2026
97,160
Depreciation and impairment
At 1 March 2025
36,011
Depreciation charged in the year
11,217
At 28 February 2026
47,228
Carrying amount
At 28 February 2026
49,932
At 28 February 2025
55,205
6
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
98,448
88,314
Other debtors
16,972
3,266
115,420
91,580
MEDICO LEGAL SCOTLAND LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2026
- 7 -
7
Creditors: amounts falling due within one year
2026
2025
£
£
Bank loans
6,601
6,541
Trade creditors
12,505
5,090
Taxation and social security
60,819
44,326
Other creditors
15,035
25,393
94,960
81,350
8
Creditors: amounts falling due after more than one year
2026
2025
£
£
Bank loans and overdrafts
4,126
12,058
Other creditors
6,197
13,633
10,323
25,691
9
Called up share capital
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of £1 each
1
1
1
1
Ordinary B shares of £1 each
1
1
1
1
2
2
2
2
2026-02-28 2025-03-01 false false false 01 July 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity S Robertson C Robertson C Robertson SC525705 2025-03-01 2026-02-28 SC525705 2026-02-28 SC525705 2025-02-28 SC525705 core:IntangibleAssetsOtherThanGoodwill 2026-02-28 SC525705 core:IntangibleAssetsOtherThanGoodwill 2025-02-28 SC525705 core:OtherPropertyPlantEquipment 2026-02-28 SC525705 core:OtherPropertyPlantEquipment 2025-02-28 SC525705 core:WithinOneYear 2026-02-28 SC525705 core:WithinOneYear 2025-02-28 SC525705 core:CurrentFinancialInstruments core:WithinOneYear 2026-02-28 SC525705 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 SC525705 core:Non-currentFinancialInstruments core:AfterOneYear 2026-02-28 SC525705 core:Non-currentFinancialInstruments core:AfterOneYear 2025-02-28 SC525705 core:CurrentFinancialInstruments core:AfterOneYear 2026-02-28 SC525705 core:CurrentFinancialInstruments core:AfterOneYear 2025-02-28 SC525705 core:ShareCapital 2026-02-28 SC525705 core:ShareCapital 2025-02-28 SC525705 core:RetainedEarningsAccumulatedLosses 2026-02-28 SC525705 core:RetainedEarningsAccumulatedLosses 2025-02-28 SC525705 core:ShareCapitalOrdinaryShareClass1 2026-02-28 SC525705 core:ShareCapitalOrdinaryShareClass1 2025-02-28 SC525705 core:ShareCapitalOrdinaryShareClass2 2026-02-28 SC525705 core:ShareCapitalOrdinaryShareClass2 2025-02-28 SC525705 core:ShareCapitalOrdinaryShares 2026-02-28 SC525705 core:ShareCapitalOrdinaryShares 2025-02-28 SC525705 bus:Director1 2025-03-01 2026-02-28 SC525705 core:IntangibleAssetsOtherThanGoodwill 2025-03-01 2026-02-28 SC525705 core:ComputerSoftware 2025-03-01 2026-02-28 SC525705 core:PlantMachinery 2025-03-01 2026-02-28 SC525705 core:FurnitureFittings 2025-03-01 2026-02-28 SC525705 core:ComputerEquipment 2025-03-01 2026-02-28 SC525705 core:MotorVehicles 2025-03-01 2026-02-28 SC525705 2024-03-01 2025-02-28 SC525705 core:IntangibleAssetsOtherThanGoodwill 2025-02-28 SC525705 core:OtherPropertyPlantEquipment 2025-02-28 SC525705 core:OtherPropertyPlantEquipment 2025-03-01 2026-02-28 SC525705 bus:OrdinaryShareClass1 2025-03-01 2026-02-28 SC525705 bus:OrdinaryShareClass2 2025-03-01 2026-02-28 SC525705 bus:OrdinaryShareClass1 2026-02-28 SC525705 bus:OrdinaryShareClass1 2025-02-28 SC525705 bus:OrdinaryShareClass2 2026-02-28 SC525705 bus:OrdinaryShareClass2 2025-02-28 SC525705 bus:AllOrdinaryShares 2026-02-28 SC525705 bus:AllOrdinaryShares 2025-02-28 SC525705 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 SC525705 bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 SC525705 bus:FRS102 2025-03-01 2026-02-28 SC525705 bus:AuditExemptWithAccountantsReport 2025-03-01 2026-02-28 SC525705 bus:Director2 2025-03-01 2026-02-28 SC525705 bus:CompanySecretary1 2025-03-01 2026-02-28 SC525705 bus:FullAccounts 2025-03-01 2026-02-28 xbrli:pure xbrli:shares iso4217:GBP